DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
BankPosition in NBIX — Neurocrine Biosciences Inc
CIK 1694217
FRANKFURT AM MAIN, 2M
Position in NBIX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$14,201,045
+$14,106,303 QoQ
Shares Held
107,796
+16037.1% QoQ
Ownership
0.107%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
14 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main holds $52,318,865 across 12 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (27.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
502,931 | $15,148,281 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
107,796 | $14,201,045 | |
| 3 | ZTS |
Zoetis Inc.
|
55,580 | $6,570,110 | |
| 4 | BHC |
Bausch Health Companies Inc.
|
1,113,755 | $6,014,277 | |
| 5 | RDY |
Dr Reddys Laboratories Ltd
|
400,000 | $5,540,000 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
52,809 | $2,729,697 | |
| 7 | ALKS |
Alkermes plc.
|
37,964 | $1,342,407 | |
| 8 | UTHR |
UNITED THERAPEUTICS Corp
|
966 | $572,818 |
All Filings in NBIX
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,201,045 | 107,796 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $94,742 | 668 | Shares | Defined | 2026-02-17 | |
| 2024-06-30 | $1,668,835 | 12,122 | Shares | Defined | 2026-05-04 | |
| 2024-03-31 | $3,926,030 | 28,466 | Shares | Defined | 2026-05-04 | |
| 2023-12-31 | $2,439,009 | 18,511 | Shares | Defined | 2026-05-04 | |
| 2023-09-30 | $2,303,999 | 20,480 | Shares | Defined | 2026-05-04 | |
| 2023-06-30 | $3,800,384 | 40,301 | Shares | Defined | 2026-05-04 | |
| 2023-03-31 | $5,048,448 | 49,876 | Shares | Defined | 2024-05-17 | |
| 2022-12-31 | $6,228,437 | 52,147 | Shares | Defined | 2024-05-17 | |
| 2022-09-30 | $3,739,016 | 35,204 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,139,346 | 11,688 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,095,750 | 11,688 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,448,486 | 17,007 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $451,064 | 4,703 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||